APPLICATIONS PUBLISHED 30 JULY 2003
Published: 1-Jan-2004
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Method of treating stroke
Eli Lilly 1330233*
Method and dermatological and/or cosmetic compsn for inhibiting the adhesion effect of circulating cells
Sephra 1330235*
Formulation containing amoxicillin
Beecham Pharmaceuticals 1330236*
Delivery system for entrapping charged macromolecules and a method for preparing same
Les Laboratoires Bio-Med 1330237*
Pharmaceutical formulations containing a non-steroidal anti-inflammatory drug and a proton pump inhibitor
Andrx Corp 1330238*
Delayed and sustained release formulations and method of use thereof
Mehta 1330239*
Use of 20-hete synthesising enzyme inhibitors as therapy for cerebral vascular diseases
MCW Research Foundation 1330240*
Use of tolterodone to treat asthma
Pharmacia & Upjohn 1330241*
Antiproliferative colchicine compsns and uses thereof
Chemgenex Therapeutics 1330242*
Use of carp inhibitors for the treatment of heart diseases
Merck Patent 1330243*
Compsns comprising modafinil compounds
Cephalon 1330244*
Pravastatin sodium substantially free of pravastatin lactone and compsns containing same
Biogal Gyogyszergyar 1330245*
Use of hydroxyeicosatetraenoic acid derivatives in intraocular surgery
Alcon 1330246*
Use of 1-EBIO in the treatment of bipolar disorders
Glaxo Group 1330247*
New treatment for restless legs syndrome
Pharmacia & Upjohn 1330248*
Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
Otsuka Pharmaceutical 1330249*
Rapidly disintegrating sustained release cefuroxime axetil compsn
Lupin Limited 1330250*
Combination therapy for the treatment of oestrogen-sensitive disease
Biomedicines 1330251*
In vivo stimulation of angiogenic activity
Ludwig Institute for Cancer Research; Aventis Pharma; Licentia 1330252*
Use of bioactive fraction from cow urine distillate ('Go Mutra') as a bioenhancer of anti-infective anti-cancer agents and nutrients
Council of Scientific and Industrial Research 1330253*
Treatment of cancers by aplidine in conjunction with a myoprotector
Pharma Mar 1330254*
Use of a preparation of cimicifuga racemosa
Schaper & Bruemmer 1330255*
Method for determining prion strain
The Regents of the University of California 1330256*
GNRH analogues for treatment of urinary incontinence
University of Zurich 1330257*
Kahalide F formulation
Pharma Mar 1330258*
Epitope-beta microglobulin polynucleotide for anti-cancer immunotherapy
Isis Innovation 1330259*
Use of IL-1 inhibitors and TNF antagonists with recombinant erythropoietins, for the treatment of anaemia
Amgen 1330260*
Treatment of hibernating myocardium and diabetic cardiomyopathy with GLP-1 peptide
Restoragen 1330261*
Use of enzymes obtained from ciliates as medicaments for promoting digestion
Cillan 1330262*
Method for down-regulating IGE
Pharmexa 1330263*
Vaccine for treating allergy
SmithKline Beecham Biologicals 1330264*
Formulations comprising dextrin polymers in combination with sugars for the delivery of nucleic acids
ML Laboratories 1330265*
Method for making very fine particles consisting of a principle inserted in a host molecule
Separex 1330266*
Olfactory neuron cultures and method of making and using the same
Panacea Pharmaceuticals 1330267*
Targeted therapeutic agents
Targesome 1330268*
Method of inactivating micro-organisms
Photobiochem 1330269*
Sustained release device for treating conditions of the joint
Control Delivery Systems 1330270*
Use of transcription factors for treating inflammation and other diseases
Beth Israel Deaconess Medical Center 1330271*
Hot melt wetness indicator adhesive compsn
Ato Findley 1330272*
